Adult Hodgkin Lymphoma Treatment–for health professionals (PDQ®)
Changes to This Summary (11/05/2015)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Added Chowdhry et al. as reference 17 and Dores et al. as reference 18.
Added text to state that the recommendations for posttreatment follow-up are not evidence based, but a variety of opinions have been published for high-risk patients who present with advanced-stage disease or for patients who achieve less-than-complete remission by positron emission tomography–computed tomography scans at the end of therapy (cited Hoppe et al. as reference 64, Ng et al. as reference 65, Armitage as reference 66, and Picardi et al. as reference 67).
Added Advani et al. as reference 22.
Added text to state that recommendations for posttreatment follow-up are not evidence based, but a variety of opinions have been published for high-risk patients who present with advanced-stage disease or for patients who achieve less-than-complete remission by positron emission tomography–computed tomography scans at the end of therapy (cited Hoppe et al. as reference 1, Ng et al. as reference 2, Armitage as reference 3, and Picardi et al. as reference 4).
This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
No hay comentarios:
Publicar un comentario